Haemonetics's Revenue in the fiscal year 2026 $ 1,333.59 millions
Haemonetics's Revenue in the fiscal year 2025 $ 1,359.96 millions
Haemonetics's Revenue in the fiscal year 2024 $ 1,308.55 millions
Haemonetics's Revenue in the fiscal year 2023 $ 1,168.10 millions
Haemonetics's Revenue in the fiscal year 2022 $ 992.50 millions
HAE Revenue second quarter 2027 Y/Y Growth Comment
Haemonetics Corporation achieved in the second quarter 2027, above Company average Revenue improvement of 9.49% year on year, to $ 357.76 millions.
Looking into second quarter 2027 results within Medical Equipment & Supplies industry 112 other companies have achieved higher Revenue growth. While Haemonetics Corporation' s Revenue increase of 9.49% ranks overall at the positon no. 2229 in the second quarter 2027.
Revenue by Quarter for the Fiscal Years 2024, 2025, 2026, 2027
Haemonetics's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
23.63 %
-1.97 %
-100 %
(Sep 29 2012)
HAE's II. Quarter Q/Q Revenue Comment
Haemonetics Corporation achieved in the II. Quarter 2027 above company average sequential Revenue increase of 5.42%, to $ 357.76 millions, from $339.38 millions in the first quarter. HAE is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Medical Equipment & Supplies industry 83 other companies have achieved higher Revenue quarter on quarter growth. While Haemonetics's Revenue growth quarter on quarter, overall rank is 2180.
Haemonetics Corporation achieved in the II. Quarter 2027 above company average sequential Revenue increase of 5.42%, to $ 357.76 millions, from $339.38 millions in the first quarter. HAE is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Medical Equipment & Supplies industry 83 other companies have achieved higher Revenue quarter on quarter growth. While Haemonetics's Revenue growth quarter on quarter, overall rank is 2180.
Haemonetics's 12 Months Revenue Growth Year on Year
Although Haemonetics's Annual Revenue growth year on year were below company's average 6.4952989703891E+16% , Revenue announced in the Sep 26 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 4.23% year on year, from 0.48% in Jun 27 2026.
In the Healthcare sector 322 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1798 to 2162.
Although Haemonetics's Annual Revenue growth year on year were below company's average 6.4952989703891E+16% , Revenue announced in the Sep 26 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 4.23% year on year, from 0.48% in Jun 27 2026.
In the Healthcare sector 322 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1798 to 2162.
About Haemonetics Revenue Growth Rates (HAE), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
16.45%